Does Teva Pharmaceutical Industries (TEVA) Have the Potential to Rally 28.12% as Wall Street Analysts Expect?

Teva Pharmaceutical Industries Ltd. (TEVA) closed the last trading session at $19.42, gaining 2.9% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of$ 24.88 indicates a 28.1% upside potential.The average comprises eight short-term price targets ranging from a low of $20.00 to a high of$ 29.00, with a standard deviation of $2.53. While the lowest estimate indicates an increase of 3% fr ...